A multifaceted health-service intervention in remote Aboriginal communities: 3-year follow-up of the impact on diabetes care by Bailie, Ross S. et al.
INDIGENOUS HEALTHA multifaceted health-service intervention in remote Aboriginal 
communities: 3-year follow-up of the impact on diabetes care
Ross S Bailie, Damin Si, Gary W Robinson, Samantha J Togni and Peter H N d’AbbsMenzies School of Health Research; Institute of Advanced Studies, Charles Darwin University, 
Darwin, NT.
Ross S Bailie, MPhil(MCH), MD, Associate Professor in Public Health; Damin Si, MMed, Research 
Scholar; Samantha J Togni, MA, Project Manager/Research Officer. 
School of Humanities, Social Sciences and Management, Charles Darwin University, Darwin, NT.
Gary W Robinson, PhD, Acting Associate Dean. 
School of Public Health and Tropical Medicine, James Cook University, Cairns, QLD.
Peter H N d’Abbs, PhD, Associate Professor. 
Reprints will not be available from the authors. Correspondence: Associate Professor Ross S Bailie, 
Menzies School of Health Research, PO Box 41096, Casuarina, NT 0811. rossb@menzies.edu.auThe Medical Journal of Australia ISSN:
0025-729X 16 August 2004 181 4 195-
200
©The Medical Journal of Australia 2004
www.mja.com.au
Indigenous Health
ness of such interventions,4 or on the impact
of broader healthcare system reforms on
specific aspects of care. Recent health reform
initiatives — the “c ordinated care trials”
(CCTs) — in two remote regions of the
Northern Territory aimed to enhance gov-
ernance and funding arrangements. A health
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Objective:  To examine the trends in processes of diabetes care and in participant 
outcomes after an intervention in two remote regions of Australia.
Design:  Follow-up study over 3 years.
Setting:  Seven health centres in the Tiwi Islands and the Katherine West region of the 
Northern Territory.
cipants:  137 Aboriginal people with type 2 diabetes.
vention:  Implementation of a multifaceted trial, including transfer of purchasing 
lanning responsibility to local health boards, the development and dissemination 
nical guidelines supported by electronic registers, recall and reminder systems and 
iated staff training, and audit and feedback.
 outcome measures:  Trends in the proportion of Aboriginal people receiving 
services in accordance with clinical guidelines and in the proportion for whom specified 
levels of blood pressure and glycosylated haemoglobin (HbA1c) were achieved; health 
staff perceptions of barriers to effective service delivery.
Results:  An initial improvement in overall service levels from 40% to 49% was not fully 
sustained over the 3-year period. The overall proportion of services delivered varied 
from 22% to 64% between communities and over time. The proportion of participants 
whose most recent HbA1c level was less than 7% improved from 19% to 32%, but there 
was little change in blood pressure control. Perceived barriers to service delivery 
included discontinuities in staffing, lack of work-practice support and patients’ 
acceptance of services.
Conclusions:  Multifaceted interventions can improve quality of care in this 
environment, but achieving sustainable, high-quality care in a range of services and 
local conditions presents particular challenges. Developing and testing strategies 
for consistent and sustained improvement should be a priority for service providers 
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and researchers.nd
hig
2 I igenous Australians experience bothh rates1 and early age of onset2 of typediabetes. Interventions to improve the
medical management of diabetes in primary
care have been shown to improve process
and outcomes of care.3 However, there is
limited research on the long-term effective-
board was established in each region with
the responsibility for planning and purchas-
ing a wide range of healthcare services for
the population, and government funds were
transferred to these health boards.5,6
Improved coordination of care for chronic
illness was also a major aim of the trials,
with the implementation of locally devel-
oped clinical-practice guidelines supported
by an electronic-care planning, recall and
reminder system.7
We report on changes in levels of compli-
ance with diabetes-care guidelines, proc-
esses of care, and participant outcome
measures before and after implementation of
the multifaceted health-service intervention.
METHODS
Study setting and population
The trial was conducted in two remote
regions of the Northern Territory which
differ significantly — the Tiwi Islands and
the Katherine West region (Box 1). The Tiwi
Islands cover 7900 km2 and are located
about 60 km north of Darwin. An estimated
90% of the population of 2000 are Aborigi-
nal.6 The two islands contain three main
communities and a number of smaller settle-
ments. The Katherine West region covers
162 000 km2 and includes several large Abo-
riginal communities and smaller outstations,
a number of cattle stations, and a small
township. The southernmost community is
about 890 km from Darwin. About 85% of
the regional population of 2800–3000 are
Aboriginal, drawn from 10 language
groups.5 By Australian standards, the health
and socioeconomic profiles of both regions
are very poor.
The nature of the intervention meant that
everyone using the healthcare services in
these regions was subject to the interven-
tion. Signed consent was required from indi-
viduals to use their health records for trial
evaluation purposes. At the end of the first,
intensive recruitment phase of the trial,
1205 people in the Tiwi Islands (about 60%
of the population) and 1340 people in the
Katherine West region (about 45% of the
population) had provided consent. The
study was approved by the local formally
constituted ethics committee in accordance
with National Health and Medical Research
Council guidelines.
Intervention
The clinical guidelines, electronic systems to
support the guidelines, and associated staffJA • Volume 181 Number 4 • 16 August 2004 195
INDIGENOUS HEALTHtraining were introduced progressively,
starting in late 1998. Three aspects of the
intervention and associated evaluation were
expected to directly affect clinical practice.
Firstly, each health centre received a com-
prehensive set of evidence-based clinical
guidelines, including specific guidelines on
diabetes management.7 Services and service
intervals specified in the guidelines are
shown in Box 2 (columns 1 and 2).
Secondly, the guidelines were incorporated
into a computerised information system,
which was installed in all participating com-
munity health centres. The system provided
the facility for scheduling guideline services
for individual participants, for identification
of people due for scheduled services, and
reminders to clinicians. Two non-Indigenous
health department staff were engaged to visit
the health centres to train health centre staff
in using the software packages.
Thirdly, a “clinical audit cycle”8 was imple-
mented, with audits conducted at baseline,
and 6, 12, 24 and 36 months after com-
mencement of the trials. Findings from the
audits were fed back to, and their interpreta-
tion discussed with, health centre clinicians
and managers. This usually occurred within
a few months of each audit, and within a
timeframe which allowed a response to feed-
back to influence the next audit.
Study design and sampling
The population sample was followed up
over 3 years to assess changes in clinical
practice after the intervention. Of people
who consented, 188 were identified from
health centre records as having a diagnosis
of type 2 diabetes. A stratified sampling
design was used to ensure the sample
included participants from each community.
Because of small numbers in each of the five
smaller communities, all people with diabe-
tes living in these communities who con-
sented were included in the sample (n = 57).
In each of the two larger communities, a
random sample of consenting people with
diabetes was drawn (n = 83). The total sam-
ple at baseline therefore included 140 peo-
ple. The records of three were not available
for the baseline audit because of flooding.
Out-migration and death resulted in a loss
to follow-up of four members of the sample
at the Year 1 audit, another 10 at the Year 2
audit, and 16 at the Year 3 audit. The sample
at the Year 3 audit was supplemented with
the recruitment of an additional 39 consent-
ing participants from six of the communi-
ties, giving a total sample at the Year 3 audit
of 146.
Audit method
Clinical records of the participants were
audited for a record of delivery of each
service specified in the guidelines. Baseline
audits conducted around the same time as
the introduction of the guidelines recorded
services delivered over the preceding 12
months (before the introduction of the
guidelines could have had an effect).
Both the paper and electronic record of
each participant were checked for the most
recent record of delivery of each service
according to a schedule specified in the
clinical guidelines. A service was recorded as
delivered if there was a record of delivery
within 3 or 6 months (in line with recom-
mended service intervals) preceding each
audit, except where service intervals were
more than 6 months (yearly for influenza
vaccination, and every 5 years for pneumo-
coccal vaccination).
Information on attendance at health cen-
tres within the last 3 and 6 months for each
participant was also collected at Year 1, Year
2 and Year 3 audits to determine the propor-
tion of the population attending the health
centre within specified times, and the extent
of possible missed opportunities for delivery
of preventive services at times when partici-
pants were attending for other reasons.
Process and outcome measures
Processes of care were measured by assessing
adherence to guideline service schedules for
each audit period. Two types of process meas-
ures were determined for each participant:
• each service was recorded as delivered or
not; and
• the percentage of delivered services was
calculated (with delivered services as
numerator and scheduled services as
denominator).
Data on current medication were also
collected at each audit.
Four outcomes were assessed:
• most recent blood pressure level during
the 12 months preceding each audit;
• proportion of participants with “control-
led blood pressure” (< 140/90 mmHg) and
“target blood pressure” (130/80 mmHg);
• most recent glycosylated haemoglobin
(HbA1c) level in the 12 months preceding
each audit; and
• proportion of participants with “control-
led glycaemia” (HbA1c level < 8%) and “tar-
get glycaemia” (HbA1c level < 7%).
Statistical analyses
Multilevel analysis9 was conducted with the
participant and the health centre defined as
Level 1 and Level 2 units, respectively. The
regression coefficient of the time variable
(value of 0, 0.5, 1, 2, 3 for each audit
respectively) was used to indicate the aver-
age magnitude of improvement in delivery
of scheduled services per year from baseline,
with the associated P value indicating a
significant increasing or decreasing trend in
delivery of services from year to year across
the full period of follow-up.
A logistic (random-effects) model was
used for the dichotomous outcome for each
process outcome and participant outcome in
terms of, for example, the percentage of the
sample with “controlled blood pressure” and
“controlled glycaemia”. A linear random-
effects model was used for participant-based
continuous outcome measures (systolic and
diastolic blood pressure and HbA1c levels).
Separate analyses were conducted for each
community. Mean values for the continuous
outcome measures (and associated confi-
dence intervals), where appropriate, were
also calculated. All multilevel analyses were
performed using Stata version 7.010 (com-
mands xtlogit and xtreg with defined iis for
Level 2 and tis for Level 1 identifiers).
Qualitative research
In-depth interviews and observation of man-
agement and health staff meetings over the
course of the trials and follow-up period pro-
vided insights into the management of health
centres and processes of service delivery.5,6,11
RESULTS
Demographic characteristics and 
health-centre attendance
The sample comprised 52 men and 85
women (age range, 23–86 years, 70% < 55
1 Northern Territory, showing the 
Tiwi Islands and Katherine West 
Coordinated Care Trial regions
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2 Proportion of scheduled services delivered to participants with diabetes (%)*
Scheduled 
frequency 
(months)
Percentage of services delivered
Scheduled services
Baseline
(n = 137)
Month 6
(n = 137)
Year 1
(n = 133)
Year 2
(n = 123)
Year 3
(n = 146) Odds ratio (95% CI)† P for trend‡
Basic measurements 
Weight 3 77 72 70 59 51 0.64 (0.55–0.75) < 0.001
Blood pressure 3 88 80 81 76 76 0.80 (0.67–0.95) 0.01
Waist circumference 3 34 34 40 42 32 0.97 (0.84–1.13) 0.74
Body mass index 6 29 25 19 27 28 1.02 (0.86–1.20) 0.86
Blood glucose (test strip) 3 85 79 73 70 71 0.78 (0.66–0.91) 0.002
Urine dipstick testing 6 63 60 62 42 45 0.73 (0.63–0.84) < 0.001
Clinical examinations
Heart auscultation 6 22 31 12 15 12 0.69 (0.57–0.85) < 0.001
Peripheral pulses 6 9 31 34 17 33 1.24 (1.05–1.45) 0.009
Visual acuity 6 31 37 56 49 57 (145)§ 1.38 (1.19–1.60) < 0.001
Cataracts 6 28 34 47 46 52 (145)§ 1.36 (1.18–1.58) < 0.001
Optic fundi 6 29 39 49 46 56 (145)§ 1.38 (1.19–1.60) < 0.001
Feet: sensation 6 8 18 40 27 38 1.58 (1.34–1.86) < 0.001
Feet: reflexes 6 4 6 28 24 19 1.49 (1.23–1.80) < 0.001
Feet: pressure areas 6 6 7 33 23 27 1.61 (1.34–1.93) < 0.001
Feet: infection 3 17 9 37 22 29 1.30 (1.10–1.54) 0.002
Ophthalmologist 24 39 39 59 53 67 (145)§ 1.45 (1.25–1.68) < 0.001
Vaccinations¶
Pneumococcal 60 – – 74 (69)¶ 91 91 1.77 (1.14–2.74) 0.01
Influenza 12 – – 71 (69)¶ 84 81 1.07 (0.74–1.53) 0.73
Counselling/inquiry**
History of personal or 
family illness
3 74 31 50 33 1 0.35 (0.28–0.42) < 0.001
Diet 3 45 37 56 41 27 0.79 (0.68–0.92) 0.002
Activity 3 29 31 41 31 19 0.80 (0.68–0.95) 0.01
Weight loss 3 23 18 21 28 4 0.70 (0.57–0.86) 0.001
Smoking 3 31 29 39 30 24 0.85 (0.71–1.01) 0.06
Alcohol 3 34 26 38 30 18 0.75 (0.63–0.89) 0.001
Vaccinations†† 6 44 65 67 (64)†† –†† –†† 2.43 (1.25–4.71) 0.009
Diabetes control 
and medications
6 73 65 71 71 48 0.74 (0.64–0.86) < 0.001
Investigations
Albumin to creatinine ratio 6 53 46 65 46 50 0.92 (0.80–1.07) 0.29
Urea level 6 53 54 61 57 69 1.22 (1.06–1.42) 0.007
Creatinine level 6 57 56 61 58 69 1.15 (0.99–1.33) 0.07
HbA1c level 3 56 58 62 56 70 1.16 (1.00–1.35) 0.04
Fasting lipid levels 6 16 27 41 42 52 1.65 (1.42–1.93) < 0.001
* Proportions were calculated using n as denominator, unless otherwise indicated by an alternative denominator shown in parentheses.
† Odds ratios represent the average changing of probability for the delivery of each service with the increase of one unit of time (1 year), using two-level logistic 
random-effect model. 
‡ P values significant at the 0.05 level are shown in bold. 
§ Clinical examinations of visual acuity, cataracts and optic fundi, and ophthalmologist examination were not applicable to one participant who was blind. 
¶ Records of providing pneumococcal and influenza vaccines were considered as evidence for vaccinations at Year 2 and Year 3 audits; these audits were introduced 
at Year 1 in Katherine West. 
** Counselling/inquiry refers to a record of discussion of, or inquiry about, significant personal or family history of, for example, illness, dietary habits, physical activity. 
†† Audits of counselling/inquiries about vaccinations were replaced by audits of vaccination records at Year 1 in Katherine West and at Year 2 and Year 3 elsewhere. 
INDIGENOUS HEALTHyears and 18% < 35 years). There was a
record of attendance at the health centres for
93%–96% of the sample within 6 months,
and 86%–94% within 3 months preceding
each of the audits.
Trends in service delivery
During the first 6 months of the interven-
tion, there was little change in the percent-
age of overall delivered services (40% to
39%). This was followed by a significant
improvement at Year 1 (49%), with subse-
quent decline in Years 2 and 3 to close to
baseline (44% in each year). There was no
significant linear trend across the full study
period (P for trend, 0.16). This pattern was
the same for male and female participants.
There was a significant increase in the pro-
portion of people in the sample taking oral
hypoglycaemic agents (75% at baseline to
79% at Year 3; P for trend, 0.001), insulin
(4.4% to 6.8%; P for trend, 0.001), and
angiotensin-converting enzyme (ACE)
inhibitors (70.8% to 83.6%; P for trend,
0.0001).
There were wide variations in the trends
for specific services over the study period
(Box 2). Delivery of almost all services in the
categories of clinical examination, labora-
tory investigation and vaccination increased
significantly.
Delivery of most services relating to basic
measurements tended to decrease. Delivery
of counselling about diet, activity, weight,
smoking, alcohol and medication fluctuated
from baseline to Year 2, but declined sub-
stantially at Year 3. Rates of delivery of
services that were being delivered at low
levels at baseline tended to improve across
the study period, while those being deliv-
ered at higher levels at baseline tended to
decline.
Trends in service delivery varied between
communities (Box 3). In all three Tiwi com-
munities there was an increasing trend to
Years 1 and 2, followed by a decline to Year
3. In two of these communities, the overall
increasing trend was statistically significant.
In Katherine West there was more variation
between communities. A striking feature of
the patterns was the sharp decline in two
communities between Year 1 and Year 2. For
one of these communities, the overall trend
was a statistically significant decline.
Participant outcomes
There were no statistically significant trends
in the mean systolic or mean diastolic blood
pressures, or in the proportion of partici-
pants in whom targeted levels of blood
pressure control were achieved across the
study period (Box 4). There was also no
statistically significant trend in mean HbA1c
level or in the proportion of participants
with HbA1c level < 8%. However, the pro-
portion in whom a target HbA1c level < 7%
was achieved increased significantly from
19% at baseline to 32% at Year 3.
Interviews with health centre staff and
health service managers identified that the
following factors were the main barriers to
delivering and sustaining best-practice
chronic disease care:
• discontinuities in staffing;
• lack of ongoing training and support for
the care coordination process;
• lack of development of relevant work
practices;
• lack of capacity to monitor service activ-
ity through timely analysis of service data;
and
• reluctance on the part of patients to
accept offered services when presenting for
acute, non-scheduled services.
DISCUSSION
An initial improvement in overall service
delivery after implementation of the health
services intervention was not sustained over
3 Trends in mean percentages of 
services delivered to participants*
* P values for trends:  A, 0.003; B, 0.31; C, 0.29; 
D, 0.07; E, 0.01; F, 0.048; G, 0.33. P values  were 
obtained from a linear random-effect model 
accounting for repeated measures.
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4 Trends in control of blood pressure and glycosylated haemoglobin (HbA1c) levels over 3-year follow-up*
Outcomes† Baseline Month 6 Year 1 Year 2 Year 3 P for trend‡
Blood pressure (BP)
Mean systolic BP (mmHg) 128 (124–131) 130 (126–133) 129 (125–133) 126 (122–130) 128 (125–131) 0.60
Mean diastolic BP (mmHg) 78 (76–80) 80 (78–82) 78 (76–81) 77 (74–79) 80 (78–82) 0.80
% with BP < 140/90 mmHg 66 (57–74) 60 (51–68) 57 (48–66) 63 (53–72) 66 (57–74) 0.65
% with BP < 130/80 mmHg 39 (31–48) 35 (27–44) 31 (23–40) 39 (30–49) 28 (20–36) 0.13
HbA1c
Mean HbA1c (%) 9.0 (8.6–9.4) 9.2 (8.8–9.7) 9.2 (8.7–9.6) 8.9 (8.3–9.4) 8.8 (8.3–9.2) 0.23
% with HbA1c < 8.0% 39 (29–49) 37 (28–47) 37 (30–47) 44 (34–55) 44 (35–53) 0.24
% with HbA1c < 7.0% 19 (12–28) 16 (10–24) 17 (10–26) 29 (21–40) 32 (23–41) 0.002
* Data in parentheses are 95% confidence intervals.
† Blood pressure and HbA1c levels were from the most recent measures within the 12 months preceding each audit.
‡ P values for trends of continuous outcomes were calculated using a two-level linear random-effect model. P values for trends of dichotomous outcomes were obtained 
using a two-level logistic random-effect model. P value significant at the 0.05 level is shown in bold.198 MJA • Volume 181 Number 4 • 16 August 2004
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variation in trends between different services
and between different communities. Impor-
tantly, the increase in monitoring of HbA1c
level and use of hypoglycaemic agents and
insulin was associated with an increase in
the proportion of participants achieving
HbA1c level < 7%. Monitoring of blood pres-
sure declined, but there was little change in
blood-pressure control. Our qualitative
findings suggest that there are difficulties in
maintaining systems designed to improve
practice, as well as in ensuring that health
staff continue to respond to these systems.
Political constraints and the extent of
health service reforms implemented through
the CCTs precluded a randomised study,
leaving a time-series design as the best alter-
native.12 The inclusion of several communi-
ties over an extended period before and after
the intervention enhanced validity and gen-
eralisability. However, relatively low rates of
consent, particularly in Katherine West,
mean that the possibility of bias in the
estimates of the level of service delivery
cannot be excluded. Comparison between
regions and generalisability of the findings
to other populations should be made with
caution.
A more focused diabetes intervention in
the Torres Strait reported greater positive
impacts on processes of care, intermediate
outcomes and diabetes-related admis-
sions.13 In contrast, the diffusion of energy
across the broad reform agenda of the CCTs
may have limited the potential for sustained
impact on a specific condition such as dia-
betes, which, in the context of these trials,
was used as an indicator of expected impact
on chronic illness care more generally. Nev-
ertheless, the importance of the design and
implementation of focused interventions is
highlighted by the failure to sustain
improvement in blood-pressure control in a
specialised treatment program in the Tiwi
Islands after integration of the program into
routine services.14,15
The failure to demonstrate sustained
impacts on a number of aspects of diabetes
care should be considered in the context of
high levels of care relative to national16 and
international17 reports. It should also be
considered in the context of the environ-
ment in which the trials took place, which is
characterised by heavy burdens of chronic
and acute illness, pervasive social disadvan-
tage and geographic isolation. At the same
time, evaluations of the trials themselves
demonstrated that the trials have contrib-
uted to increased resources for healthcare
services in both the Tiwi Islands and Kather-
ine West regions, and have focused commit-
ment on the part of local health services to
prevention and management of chronic dis-
ease.18 A priority in chronic illness care is for
policymakers and researchers to develop
and test strategies to sustain improvements
in care within the context of enhanced
community control. Local challenges for
achieving sustained improvement and possi-
ble strategies for overcoming these chal-
lenges identified through this research (Box
5) complement and are consistent with
international models for improving chronic
illness care.19,20
COMPETING INTERESTS
R B, G R, S T and P d’A have conducted contract
evaluations and follow-up studies of the Coordi-
nated Care Trials on behalf of the local Health
Boards of Katherine West and the Tiwi Islands. The
funders of the evaluations on which this work is
based had no influence on the preparation of the
manuscript or the decision to publish.
ACKNOWLEDGEMENTS
We would like to acknowledge the assistance of
the Health Boards and staff of the health centres
where the study was conducted. We also gratefully
acknowledge the constructive comments of five
anonymous reviewers. The article is based on work
conducted for evaluations of the Coordinated Care
Trials. These evaluations were funded by the Aus-
tralian Department of Health and Ageing.
REFERENCES
1 Zimmet P, Alberti KGMM, Shaw J. Global and
societal implications of the diabetes epidemic.
Nature 2001; 414: 782-787.
2 O’Dea K, Patel M, Kubisch D, et al. Obesity,
diabetes, and hyperlipidemia in a central Aus-
tralian aboriginal community with a long history
of acculturation. Diabetes Care 1993; 16: 1004-
1010.
3 Renders CM, Valk GD, Griffin SJ, et al. Interven-
tions to improve the management of diabetes
in primary care, outpatient, and community
settings: a systematic review. Diabetes Care
2001; 24: 1821-1833.
4 Renders CM, Valk GD, Franse LV, et al. Long-
term effectiveness of a quality improvement
program for patients with type 2 diabetes in
general practice. Diabetes Care 2001; 24: 1365-
1370.
5 d’Abbs PH, Togni SJ. Jirntangku Miyrta Kather-
ine West Coordinated Care Trial final report.
Darwin: Menzies School of Health Research,
2000.
6 Robinson G, Bailie R. Tiwi Coordinated Care
Trial final local evaluation report. Volumes 1 and
2. Darwin: NTU Centre for Social Research,
2000.
7 Weeramanthri T, Connors C, O’Leary S, et al.
Chronic disease guidelines and the indigenous
Coordinated Care Trials. Aust Health Rev 2002;
25: 1-6.
8 National Institute of Clinical Excellence,
National Health Service, UK. Principles for best
practice in clinical audit. Available at:
5 Some challenges and strategies for sustaining improvement in 
chronic illness care
Challenge: The local impact of clinical interventions is likely to be mediated by an array of 
contextual factors, including governance arrangements, remoteness, staffing issues, and quality 
of transportation and communications infrastructure.
Strategy: Tailor strategies to address local mediating factors. Overarching strategies include:
• providing strong systemic support from central agencies to buffer the effects of mediating 
factors on regional and local organisations;
• providing transparent work-practice systems backed by written protocols and manuals 
and appropriate staffing and training policies at regional and local levels; and
• recognising local knowledge and interest and using this to address local problems.
Challenge: A range of practitioner types (eg, general practitioners, registered nurses and 
Aboriginal health workers) are involved in delivery of care. Specific interventions may reach 
some categories of health staff more effectively than others.
Strategy: Operationalise care processes through development of work practices; delineate 
roles and practices for all practitioner types and support these with appropriate aids and 
specific in-service training.
Challenge: People may be unwilling to take up health services even when they are offered, 
limiting the intensification of care.
Strategy: Raise awareness in communities of appropriate care through developing and 
implementing education and health-promotion strategies with strong local participation.
Challenge: Response to demands for acute care may interfere with effective chronic illness care.
Strategy: Provide sustained institutional support and protected staff time for core chronic 
illness care functions. Develop acute-care processes to maximise potential for opportunistic 
chronic illness care.MJA • Volume 181 Number 4 • 16 August 2004 199
INDIGENOUS HEALTHwww.nice.org.uk/pdf/BestPracticeClinical Audit.pdf (accessed April
2004).
9 Goldstein H. Multilevel statistical models. London: Hodder Arnold, 2003.
10 StataCorp. Stata statistical software: Release 7.0. College Station, Texas:
StataCorp, 2001.
11 Robinson G, d’Abbs PH, Togni SJ, Bailie R. Aboriginal participation in
health service delivery: coordinated care trials in the Northern Territory of
Australia. Int J Healthcare Technology Management 2003; 5: 45-62.
12 Shadish WR, Cook TD, Campbell DT. Experimental and quasi-experi-
mental designs for generalized causal inference. Boston: Houghton
Mifflin Company, 2002.
13 McDermott R, Tulip F, Schmidt B, Sinha A. Sustaining better diabetes
care in remote indigenous Australian communities. BMJ 2003; 327: 428-
430.
14 Hoy WE, Baker PR, Kelly AM, Wang Z. Reducing premature death and
renal failure in Australian Aboriginals. A community-based cardiovascular
and renal protective program. Med J Aust 2000; 172: 473-478. 
15 Robinson G, Bailie R, Wang Z, Snelling P, et al. A follow-up study of
outcomes of the Tiwi Renal Treatment Program, Darwin: Northern
Territory University, 2003.
16 Australian Institute of Health and Welfare. Diabetes: Australian facts
2002. AIHW Cat. No. CVD 20 (Diabetes Series No. 3). Canberra: AIHW,
2002.
17 US Department of Health and Human Services, Agency for Healthcare
Research and Quality. National healthcare quality report December 2003.
Available at: www.qualitytools.ahrq.gov/qualityreport/documents/
quality_report.pdf (accessed Jan 2004).
18 KPMG. The Aboriginal and Torres Strait Islander Coordinated Care Trials
national evaluation report. Volume 1. Main report. Canberra: Common-
wealth Department of Health and Aged Care, 2001.
19 Wagner EH, Austin BT, Von Korff M. Organizing care for patients with
chronic illness. Milbank Q 1996; 74: 511-544.
20 Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for
patients with chronic illness. JAMA 2002; 288: 1775-1779.
 (Received 3 Dec 2003, accepted 4 May 2004) ❏
Massachusetts General Hospital handbook of general hospital
psychiatry. Stern TA, Fricchione GL, Cassem NH, et al. Philadel-
phia: Mosby, 2004 (xx + 827 pp $100.10) ISBN 0323027679.
Mood disorders. Recognition and treatment. Joyce PR, Mitch-
ell PB (eds). Sydney: UNSW Press, 2004 (xvi + 508 pp $59.95)
ISBN 0868404470.
Netter’s concise atlas of orthopaedic anatomy. Thompson JC.
Teterboro, NJ: Icon Learning Systems, 2002 (ix + 320 pp
$146.30) ISBN 0914168940.
Netter’s internal medicine. Runge MS, Greganti MA (eds).
Teterboro, NJ: Icon Learning Systems, 2002 (xxxii + 1111pp
$118.80) ISBN 1929007000.
Netter’s obstetrics, gynaecology and women’s health. Smith
RP. Teterboro, NJ: Icon Learning Systems, 2002 (xiii + 578 pp
$118.80) ISBN 1929007256.
Prevention and treatment of ischemic stroke. Kasner SE,
Gorelick PB (eds). Philadelphia: Butterworth Heinemann, 2004
(xv + 416 pp $171.60) ISBN 0750674644.
Project management in health and community services. Dwyer
J, Stanton P, Thiessen V. Sydney: Allen and Unwin, 2004 (xxi +
200 pp $45) ISBN 1741140552.
Rapid reference. Diabetes and related disorders. Ross S,
Gadsby R. London: Mosby, 2004 (vi + 148 pp $41.80) ISBN
0723433178.
Reading doctors’ writing. Race, politics and power in Indige-
nous health research, 1879-1969. Thomas DP. Canberra: Abo-
riginal Studies Press, 2004 (xvi + 209 pp $29.95) ISBN
0855754583.
Rheumatoid arthritis. Your questions answered. Moots RJ,
Jones N. Edinburgh: Churchill Livingstone, 2004 (151 pp $52.80)
ISBN 0443074429.
BO OKS RECEIVED200 MJA • Volume 181 Number 4 • 16 August 2004
